EUCTR2005-006209-16-IT进行中（未招募）不适用
Evaluation of the role of 18F-di-idrossi-fenil-alanina 18F-DOPA in images diagnostic by Positron Emission Tomography PET in study of human neuroendocrin neoplasia. - ND
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点目标入组 100 人开始时间: 2006年5月9日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adult subjects age 18 years of both sex, carriers of neuroendocrin neoplasie. Patients in pediatric age affections from neuroblastoma
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- subject unsound of mind; - age 18 years; - women in pregnancy; - women in breast-feeding; - patients in emergency situation.
研究者
相似试验
已完成
不适用
A study of usefulness of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the initial staging and assessment of response to treatment in locally advanced breast cancerCTRI/2018/04/013455Sri Venkateswara Institute of Medical Sciences
已完成
不适用
18-Fluorothymidine positron emission tomography (18-FLT PET/CT) to assess tumour proliferation during radical radiotherapyLung cancerCancerISRCTN97398362Guy's and St. Thomas' NHS Foundation Trust (UK)20
Unknown
不适用
Relationship Between Hypoxia and Endocrine Response in Human Breast CancerHypoxiaBreast CancerNCT01814449Fudan University130
已完成
不适用
Evaluation of 3'-deoxy-3'-[18F]fluorothymidine -PET and diffusion weighted imaging -MRI in patients with early stage non-small cell lung cancer treated with a platinum-based doublet as preoperative chemotherapy.Lungcancer10038666non-small cell lung cancerNL-OMON42040European Organisation for Research in Treatment of Cancer (EORTC)4
进行中（未招募）
1 期
Experimental study to evaluate the effect of PET/TC using 18F-PSMA label in the management of patients with prostate cancer.MedDRA version: 20.0Level: LLTClassification code 10029002Term: Neoplasm of the prostateSystem Organ Class: 100000004864Prostate cancerEUCTR2019-002000-41-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS500